Loading decisions…
Loading decisions…
2,509 vetted Board decisions in 2025.
The Board granted a disability rating of 40 percent for peripheral neuropathy in both the right and left lower extremities, effective November 11, 2020.
The Board remands the claims for further development and readjudication by the Regional Office due to a duty to assist error regarding the verification of in-service exposure to herbicide agents or other toxic exposure risk activities.
The Board granted service connection for left ulnar neuropathy as secondary to the Veteran's service-connected left elbow disability.
The Board granted readjudication of the service connection claims for various conditions based on new and relevant evidence, but remanded several claims for further development.
The Board denied higher initial ratings for diabetes mellitus, type II; right lower extremity diabetic peripheral neuropathy; and general anxiety disorder. The issues of service connection for left and right eye disabilities and entitlement to a total disability rating based on individual unemployability due to service-connected disabilities were remanded.
The Board remands the appeal for further development, specifically to obtain VA treatment records from the CBOC in Charlotte Hall, Maryland.
The Board granted 40 percent ratings for right and left lower extremity peripheral neuropathy, a 30 percent rating for left upper extremity peripheral neuropathy, and denied an increased rating in excess of 20 percent for diabetes mellitus type II.
The Board granted service connection for diabetes mellitus type II, coronary artery disease, Parkinson's disease, and neuropathy, as due to herbicide exposure or secondary to a service-connected condition.
The Veteran is granted special monthly compensation (SMC) at the rates specified in 38 U.S.C. � 1114(l), (o), and (r)(1) based on his service-connected disabilities, including bilateral lower extremity peripheral neuropathy and metatarsalgia with history of Morton's neuroma.
The appeal for service connection for early-onset peripheral neuropathy was dismissed due to an improper concurrent election.
The Board granted increased ratings for Parkinson's disease-related conditions, effective March 28, 2021, and denied higher ratings prior to that date.
The Board denied service connection for peripheral neuropathy in all extremities as there was no evidence of a current diagnosis and the claims were not supported by competent medical evidence linking the conditions to the Veteran's military service.
The Board granted service connection for diabetes, type II and peripheral neuropathy of the feet as secondary to that condition. The claims for hypertension, heart disease, colon cancer, and skin cancer were remanded.
The Veteran is granted special monthly compensation (SMC) based on a need for aid and attendance due to his service-connected disabilities, including bilateral lower extremity peripheral neuropathy and peripheral artery disease. He is also granted SMC based on loss of use of both legs.
The Veteran's service connection for diabetes mellitus, type II was granted due to exposure to herbicides during his service in Panama. Other claims were remanded.
The Board remands the claims for service connection for peripheral neuropathy of both lower extremities to obtain an addendum opinion considering all theories of entitlement, including exposure to herbicide agents and contaminated water at Camp Lejeune.
The Board granted service connection for sarcoidosis of the lung 4th stage, skin, head and remanded the claims for diabetes mellitus, type II, hypertension, joint pain (all) (also claimed as right hip), and peripheral neuropathy (also claimed as lower extremities).
The Board remands the claims for service connection of bilateral upper and lower extremity neuropathy to afford the Veteran a VA examination and medical opinion.
The Board denied earlier effective dates for ratings and denied increased ratings for peripheral neuropathy in all extremities except granted an 80 percent rating for right lower extremity peripheral neuropathy from June 10, 2021 and left lower extremity peripheral neuropathy from the same date.
The Board denied the Veteran's claims for an earlier effective date for service connection for left eye neuropathy, depression, and a TDIU.
← Back to Peripheral neuropathy overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.